Literature DB >> 12842477

Experimental models of pulmonary infection.

Irma A J M Bakker-Woudenberg1.   

Abstract

Experimental models of pulmonary infection are being discussed, focused on various aspects of good experimental design, such as choice of animal species and infecting strain, and route of infection/inoculation techniques (intranasal inoculation, aerosol inoculation, and direct instillation into the lower respiratory tract). In addition, parameters to monitor pulmonary infection are being reviewed such as general clinical signs, pulmonary-associated signs, complication of the pulmonary infection, mortality rate, and parameters after dissection of animals. Examples of pulmonary infection models caused by bacteria, fungi, viruses or parasites in experimental animals with intact or impaired host defense mechanisms are shortly summarized including key-references.

Entities:  

Mesh:

Year:  2003        PMID: 12842477     DOI: 10.1016/s0167-7012(03)00118-0

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  13 in total

1.  Aerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatment.

Authors:  Steven B Yee; Joshua M Hatkin; David N Dyer; Steven A Orr; M Louise M Pitt
Journal:  Comp Med       Date:  2010-12       Impact factor: 0.982

Review 2.  Animal Models of Aspergillosis.

Authors:  Guillaume Desoubeaux; Carolyn Cray
Journal:  Comp Med       Date:  2018-04-02       Impact factor: 0.982

3.  Murine aerosol challenge model of anthrax.

Authors:  Crystal L Loving; Mary Kennett; Gloria M Lee; Vanessa K Grippe; Tod J Merkel
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

4.  T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteria.

Authors:  Carmen M Collazo; Anda I Meierovics; Roberto De Pascalis; Terry H Wu; C Rick Lyons; Karen L Elkins
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

5.  Effect of granulocyte colony-stimulating factor combination therapy on efficacy of posaconazole (SCH56592) in an inhalation model of murine pulmonary aspergillosis.

Authors:  Andriani C Patera; Frederick Menzel; Craig Jackson; Joan K Brieland; Judy Halpern; Roberta Hare; Anthony Cacciapuoti; David Loebenberg
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

6.  Transient lipopolysaccharide-induced resistance to aerosolized Bacillus anthracis in New Zealand white rabbits.

Authors:  Steven B Yee; David N Dyer; Nancy A Twenhafel; M Louise M Pitt
Journal:  Comp Med       Date:  2013-06       Impact factor: 0.982

7.  Dynamics of interferon-gamma release assay and cytokine profiles in blood and respiratory tract specimens from mice with tuberculosis and the effect of therapy.

Authors:  J E M de Steenwinkel; G J de Knegt; M T ten Kate; H A Verbrugh; T H M Ottenhoff; I A J M Bakker-Woudenberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-09       Impact factor: 3.267

8.  Comparison and evaluation of experimental mediastinitis models: precolonized foreign body implants and bacterial suspension inoculation seems promising.

Authors:  Gulden Ersoz; Barlas Naim Aytacoglu; Nehir Sucu; Lulufer Tamer; Ismet Bayindir; Necmi Kose; Ali Kaya; Murat Dikmengil
Journal:  BMC Infect Dis       Date:  2006-04-25       Impact factor: 3.090

9.  A murine inhalation model to characterize pulmonary exposure to dry Aspergillus fumigatus conidia.

Authors:  Amanda D Buskirk; Brett J Green; Angela R Lemons; Ajay P Nayak; W Travis Goldsmith; Michael L Kashon; Stacey E Anderson; Justin M Hettick; Steven P Templeton; Dori R Germolec; Donald H Beezhold
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

10.  Development of a murine nose-only inhalation model of influenza: comparison of disease caused by instilled and inhaled A/PR/8/34.

Authors:  Larry E Bowen; Katie Rivers; John E Trombley; J Kyle Bohannon; Shixiong X Li; Jeremy A Boydston; Maryna C Eichelberger
Journal:  Front Cell Infect Microbiol       Date:  2012-05-30       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.